4.1 Letter

Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCVA® DxSelect™ antibody assay

Journal

JOURNAL OF NEUROVIROLOGY
Volume 22, Issue 6, Pages 880-881

Publisher

SPRINGER
DOI: 10.1007/s13365-016-0482-z

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available